Overview of general physiologic features and functions of vitamin D

Steenbock, 1924, The induction of growth promoting and calcifying properties in a ration by exposure to light, Science, 60, 224, 10.1126/science.60.1549.224 McCollum, 1913, The necessity of certain lipins in the diet during growth, J Biol Chem, 25, 167, 10.1016/S0021-9258(18)88553-2 Mellanby, 1919, An experimental investigation on rickets, Lancet, 1, 407 McCollum, 1922, An experimental demonstration of the existence of a vitamin which promotes calcium deposition, J Biol Chem, 53, 293, 10.1016/S0021-9258(18)85783-0 Huldshinsky, 1919, Heilung von Rachitis durch kunstalich Hohen-sonne. (The healing of rickets with artificial high altitude sun.), Dtsch Med Wochenschr, 45, 712 Chick, 1923, Studies of rickets in Vienna 1919–1922, Med Res Counc (GB) Spec Rep Ser, 77 Steenbock, 1924, Fat-soluble vitamins. XVII. The induction of growth-promoting and calcifying properties in a ration by exposure to ultraviolet light, J Biol Chem, 61, 405, 10.1016/S0021-9258(18)85139-0 Goldblatt, 1923, Studies on the fat-soluble growth-promoting factor, Biochem J, 17, 446, 10.1042/bj0170446 Askew, 1931, The distillation of vitamin D, Proc R Soc Lond, 8107, 76 Windaus, 1936, Uber das antirachitisch wirksame Bestrahlungs-produkt aus 7-Dehydrocholesterin. (Concerning the antirachitic activity of the irradiation product of 7-dehydrocholesterol.), Hoppe-Seyler's Z Physiol Chem, 241, 100, 10.1515/bchm2.1936.241.1-3.100 Velluz, 1949, Chimie organique-equilibre de réaction entre précalciférol et calciférol. (The organic chemical equilibrium of the reaction between precalciferol and calciferol.), C R Assoc Anat, 228, 853 Prader, 1961, Helv Paediatr Acta, 16, 452 Lund, 1966, Biologically active metabolite of vitamin D3 from bone, liver, and blood serum, J Lipid Res, 7, 739, 10.1016/S0022-2275(20)38950-1 Morri, 1967, Biological activity of a vitamin D metabolite, Arch Biochem Biophys, 120, 508, 10.1016/0003-9861(67)90510-3 Blunt, 1968, 25-Hydroxycholecalciferol: a biologically active metabolite of vitamin D3, Biochemistry, 7, 3317, 10.1021/bi00850a001 Blunt, 1969, The synthesis of 25-hydroxycholecalciferol: a biologically active metabolite of vitamin D3, Biochemistry, 8, 671, 10.1021/bi00830a031 Holick, 1971, Isolation and identification of 1,25-dihydroxycholecalciferol: a metabolite of vitamin D active in intestine, Biochemistry, 10, 2799, 10.1021/bi00790a023 Semmler, 1972, The synthesis of 1α,25-dihydroxycholecalciferol: a metabolically active form of vitamin D3, Tetrahedron Lett, 40, 4147, 10.1016/S0040-4039(01)94260-1 DeLuca, 1983, Vitamin D: recent advances, Annu Rev Biochem, 52, 411, 10.1146/annurev.bi.52.070183.002211 Jones, 1998, Current understanding of the molecular actions of vitamin D, Physiol Rev, 78, 1193, 10.1152/physrev.1998.78.4.1193 Rosen, 1998, Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 25-hydroxylase gene, J Biol Chem, 273, 14805, 10.1074/jbc.273.24.14805 Cheng, 2003, De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase, J Biol Chem, 278, 38084, 10.1074/jbc.M307028200 Ohyama, 1991, Isolation and characterization of a cytochrome P-450 from rat kidney mitochondria that catalyzes the 24-hydroxylation of 25-hydroxyvitamin D3, J Biol Chem, 266, 8690, 10.1016/S0021-9258(18)31501-1 Underwood, 1984, Vitamin D is not directly necessary for bone growth and mineralization, Am J Physiol, 246, E493 Suda, 2002, Vitamin D and bone, J Cell Biochem, 88, 259, 10.1002/jcb.10331 Garabedian, 1972, Control of 25-hydroxycholecalciferol metabolism by the parathyroid glands, Proc Natl Acad Sci USA, 69, 1673, 10.1073/pnas.69.7.1673 Garabedian, 1974, Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats, Endocrinology, 94, 1022, 10.1210/endo-94-4-1022 Yamamoto, 1984, Vitamin D deficiency and renal calcium transport in the rat, J Clin Invest, 74, 507, 10.1172/JCI111448 Brown, 1993, Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid, Nature, 366, 575, 10.1038/366575a0 Tanaka, 1984, Rat renal 25-hydroxyvitamin D3-1- and 24-hydroxylases: their in vivo regulation, Am J Physiol, 246, E168 Brenza, 2000, Regulation of 25-hydroxyvitamin D3 1α-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3, Arch Biochem Biophys, 381, 143, 10.1006/abbi.2000.1970 Chambers, 1982, Calcitonin alters behaviour of isolated osteoclasts, J Pathol, 136, 27, 10.1002/path.1711360104 Shinki, 1999, Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1α-hydroxylase gene in normocalcemic rats, Proc Natl Acad Sci USA, 96, 8253, 10.1073/pnas.96.14.8253 Sutton, 2003, Vitamin D: more than a “bone-a-fide” hormone, Mol Endocrinol, 17, 777, 10.1210/me.2002-0363 Rachez, 1998, A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system, Genes Dev, 12, 1787, 10.1101/gad.12.12.1787 Kimmel-Jehan, 1999, DNA binding is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements, J Cell Biochem, 74, 220, 10.1002/(SICI)1097-4644(19990801)74:2<220::AID-JCB8>3.0.CO;2-T Brown, 1990, Phosphorylation of the 1,25-dihydroxyvitamin D3 receptor: a primary event in 1,25-dihydroxyvitamin D3 action, J Biol Chem, 265, 10025, 10.1016/S0021-9258(19)38773-3 Segura, 1999, Vitamin D receptor ontogenesis in rat liver, Histochem Cell Biol, 112, 163, 10.1007/s004180050403 Fraga, 2002, Ontogensis of the vitamin D receptor in rat heart, Histochem Cell Biol, 117, 547, 10.1007/s00418-002-0413-3 Bischoff, 2001, In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue, Histochem J, 33, 19, 10.1023/A:1017535728844 Prufer, 1999, Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord, J Chem Neuroanat, 16, 135, 10.1016/S0891-0618(99)00002-2 Gascon-Barre, 2003, The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells, Hepatology, 37, 1034, 10.1053/jhep.2003.50176 Pike, 1979, Biochemical evidence for 1,25-dihydroxyvitamin D receptor macromolecules in parathyroid, pancreatic pituitary and placental tissues, Life Sci, 26, 407, 10.1016/0024-3205(80)90158-7 Sandgren, 1991, Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat, Biochem Biophys Res Commun, 181, 611, 10.1016/0006-291X(91)91234-4 Darwish, 1999, Identification of a transcription factor that binds to the promoter region of the human parathyroid hormone gene, Arch Biochem Biophys, 365, 123, 10.1006/abbi.1999.1160 Slatopolsky, 2003, Pathogenesis and treatment of renal osteodystrophy, Blood Purif, 21, 318, 10.1159/000072552 Yang, 1993, Vitamin D deficiency suppresses cell-mediated immunity in vivo, Arch Biochem Biophys, 303, 98, 10.1006/abbi.1993.1260 Yang, 1993, 1α,25-Dihydroxyvitamin D3 and 19-nor-1α,25-dihydroxyvitamin D2 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo, Biochim Biophys Acta, 1158, 269 Cantorna, 1996, 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis, Proc Natl Acad Sci USA, 93, 7861, 10.1073/pnas.93.15.7861 Zella, 2003, Vitamin D and autoimmune diabetes, J Cell Biochem, 88, 216, 10.1002/jcb.10347 Lemire, 1992, 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/1 mice, Autoimmunity, 12, 143, 10.3109/08916939209150321 Cantorna, 2000, 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease, J Nutr, 130, 2648, 10.1093/jn/130.11.2648 Cantorna, 1998, 1,25-Dihydroxyvitamin D3 prevents and ameliorates symptoms in two experimental model of human arthritis, J Nutr, 128, 68, 10.1093/jn/128.1.68 Griffin, 2001, Dendritic cell modulation by 1α,25-dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo, Proc Natl Acad Sci USA, 98, 6800, 10.1073/pnas.121172198 Hullett, 1998, Prolongation of allograft survival by 1,25-dihydroxyvitamin D3, Transplantation, 66, 824, 10.1097/00007890-199810150-00002 Sicinski, 1998, New 1α,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl and 2-methylene analogs, J Med Chem, 41, 4662, 10.1021/jm9802618 Yamamoto, 2003, 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts, J Biol Chem, 278, 31756, 10.1074/jbc.M304737200 Shevde, 2002, A novel potent analog of 1α,25-dihydroxyvitamin D3 selectively induces bone formation, Proc Natl Acad Sci USA, 99, 13487, 10.1073/pnas.202471299 Plum, 2004, Biologically active noncalcemic analogs of 1α,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl, Proc Natl Acad Sci USA, 101, 6900, 10.1073/pnas.0401656101 Binkley, 2004, Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization, J Clin Endocrinol Metab, 88, 3152, 10.1210/jc.2003-031979 Shepard, 1980, Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes, Arch Biochem Biophys, 202, 43, 10.1016/0003-9861(80)90404-X